The prevalence of pain in four cancers.
Although pain is widely recognized as a major problem in cancer patients, most studies have concentrated on pain among those with advanced or terminal cancer in specialized treatment settings. The study reported here gives a more complete picture of the problem of pain among cancer patients by providing data generalizable to those in early as well as late stages of the disease, and receiving care in the community as well as specialized treatment centers. Having included measures of several distinct features of pain, this study also provides a more complete understanding of the cancer patient's day-to-day pain problem than earlier investigations. The findings presented here indicate that serious pain may occur in all cancer stages, and often represents an ongoing medical problem. The data suggest that many patients may benefit from earlier and more aggressive use of available antipain treatment methods.
D000700:Analgesics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000503:physiopathology; D008297:Male; D009369:Neoplasms / Q000503:physiopathology*; D010146:Pain / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D010147:Pain Measurement; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000503:physiopathology; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000503:physiopathology
D000700:Analgesics